Skip to content
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Homepage
Open navigation
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Posts in: press release
heltzen
press release
investor
medicine
science
cannabinoids
korman
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery
June 24, 2026
press release
investor
eXoZymes Inc. Announces Closing of $6 Million Public Offering
June 17, 2026
press release
investor
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants
June 8, 2026
biofuel
press release
korman
eXoZymes Announces Graduation from Shell GameChanger™ Accelerator Powered by NLR (GCxN) Program
May 7, 2026
press release
nutraceuticals
medicine
press clippings
video
science
podcast
perriman
NCT
eXoZymes CCO, Damien Perriman, outlines NCTx strategy and the commercial path for cell-free biomanufacturing on Grow Everything podcast
April 10, 2026
press release
investor
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
March 31, 2026
press release
nutraceuticals
medicine
video
perriman
NCT
Video interview: Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalability
March 18, 2026
press release
nutraceuticals
medicine
perriman
NCT
eXoZymes’ CCO Damien Perriman to Present a NCT solution at next week’s MISTA Symposium
March 12, 2026
press release
investor
With refreshed brand eXoZymes sharpens pharmaceutical focus to drive platform leverage and long-term value creation
February 10, 2026
press release
investor
nutraceuticals
science
NCT
eXoZymes advancing commercial readiness with profound production metrics on initial NCT pilot run
January 29, 2026
Previous page
Page 1 of 5
Next page